• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Fifth Disease (Erythema Infectiosum) Fact Sheet

    PDF Version of this Fact Sheet

    Fifth disease is a mild rash illness

    It is caused by a human virus called parvovirus B19 and primarily affects school age children.

    Many people already have had fifth disease

    Most people get infected between 5 and 14 years of age. It is estimated that about half the adults in the United States have been infected with parvovirus B19 and therefore can not get it again.

    A red, patchy, "slapped cheek" rash on the face is common during infection

    The rash may appear on other parts of the body (such as the arms, trunk, buttocks, and thighs). Other symptoms such as fever, headache, body ache, sore throat, congestion, runny nose, cough, nausea, or diarrhea may come before the rash. In adults, joint pains or arthritis may occur. Symptoms usually start 4 to 20 days after a person has been exposed. About 25% of all cases have no symptoms. In both children and adults, the disease is usually mild and recovery occurs without problems.
    A person with fifth disease usually spreads the virus before the rash starts

    The virus is spread by exposure to airborne droplets from the nose and throat of infected people. The virus can also be transmitted by blood or blood products.

    There is a blood test, but it is not widely available

    A blood test for antibodies is used to see if a person is currently infected or was infected in the past. The blood test is used primarily for pregnant women exposed to fifth disease. In most cases, the disease is diagnosed based on the appearance of a typical rash.

    There is no specific treatment or vaccine for fifth disease at this time

    Some people are at higher risk of complications or serious illness if they get fifth disease:

    • Unborn fetuses of pregnant women who develop fifth disease. Miscarriages and stillbirths are uncommonly associated with parvovirus infection, but are more frequent when infection occurs during the first half of pregnancy. Parvovirus infection later during pregnancy can lead to severe anemia in the fetus, prematurity, or stillbirth.
    • People with immunodeficiency or chronic red blood cell disorders (such as sickle cell anemia) may get severe anemia if they catch fifth disease.

    Those at risk should check with their doctor

    Those at increased risk for serious illness or complications should realize that they might catch fifth disease from family members, others in the community, and in child care, school, or other occupational settings. Pregnant women and others at risk should consult with their physicians if they have been in contact with a case of fifth disease. The doctor may want to check the blood to see if they have already been exposed to parvovirus. Routine exclusion of those at risk from settings where fifth disease is occurring is not recommended since the risk depends on whether the person is already immune. Each exposure needs to be individually evaluated.

    Exclusion of children with fifth disease from school or day care is not recommended

    Since the greatest risk of viral spread is before symptoms begin, few control measures are necessary.